Æȷοì
karima mokhtari
karima mokhtari
¼Ò¼ÓÀ» ¾Ë ¼ö ¾øÀ½
aphp.frÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the ¡¦
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
80072009
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas
M Sanson, Y Marie, S Paris, A Idbaih, J Laffaire, F Ducray, S El Hallani, ...
J Clin Oncol 27 (25), 4150-4154, 2009
11682009
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of ¡¦
R Stupp, ME Hegi, WP Mason, MJ van den Bent, MJ Taphoorn, ...
Lancet Oncol 10 (5), 459-466, 2009
10012009
Radiotherapy for glioblastoma in the elderly
F Keime-Guibert, O Chinot, L Taillandier, S Cartalat-Carel, M Frenay, ...
New england journal of medicine 356 (15), 1527-1535, 2007
9312007
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
J Haroche, F Charlotte, L Arnaud, A Von Deimling, Z Hélias-Rodzewicz, ...
Blood, The Journal of the American Society of Hematology 120 (13), 2700-2703, 2012
6722012
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C Houillier, X Wang, G Kaloshi, K Mokhtari, R Guillevin, J Laffaire, S Paris, ...
Neurology 75 (17), 1560-1566, 2010
5782010
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
C Besson, A Goubar, J Gabarre, W Rozenbaum, G Pialoux, FP Châtelet, ...
Blood, The Journal of the American Society of Hematology 98 (8), 2339-2344, 2001
4602001
Mechanisms and therapeutic implications of hypermutation in gliomas
M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ...
Nature 580 (7804), 517-523, 2020
4372020
A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases
S Camilleri-Broët, E Criniere, P Broët, V Delwail, K Mokhtari, A Moreau, ...
Blood 107 (1), 190-196, 2006
4302006
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
S El Hallani, B Boisselier, F Peglion, A Rousseau, C Colin, A Idbaih, ...
Brain 133 (4), 973-982, 2010
4192010
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions
K Hoang-Xuan, L Capelle, M Kujas, S Taillibert, H Duffau, J Lejeune, ...
Journal of clinical oncology 22 (15), 3133-3138, 2004
4112004
A phase I/II study of herpes simplex virus type 1 thymidine kinase ¡°suicide¡± gene therapy for recurrent glioblastoma
D Klatzmann, CA Valery, G Bensimon, B Marro, O Boyer, K Mokhtari, ...
Human gene therapy 9 (17), 2595-2604, 1998
3561998
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome
G Kaloshi, A Benouaich-Amiel, F Diakite, S Taillibert, J Lejeune, ...
Neurology 68 (21), 1831-1836, 2007
3432007
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
M Labussiere, A Idbaih, XW Wang, Y Marie, B Boisselier, C Falet, S Paris, ...
Neurology 74 (23), 1886-1890, 2010
3182010
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
P Metellus, B Coulibaly, C Colin, AM de Paula, A Vasiljevic, D Taieb, ...
Acta neuropathologica 120, 719-729, 2010
3152010
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
BS Melin, JS Barnholtz-Sloan, MR Wrensch, C Johansen, D Il'Yasova, ...
Nature genetics 49 (5), 789-794, 2017
3112017
Pitfalls in the diagnosis of brain tumours
AMP Omuro, CC Leite, K Mokhtari, JY Delattre
The Lancet Neurology 5 (11), 937-948, 2006
2652006
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ...
Clinical cancer research 18 (19), 5203-5211, 2012
2592012
MGMT methylation: a marker of response to temozolomide in low‐grade gliomas
S Everhard, G Kaloshi, E Crinière, A Benouaich‐Amiel, J Lejeune, ...
Annals of Neurology: Official Journal of the American Neurological ¡¦, 2006
2522006
Detection, characterization, and inhibition of FGFR–TACC fusions in IDH wild-type glioma
AL Di Stefano, A Fucci, V Frattini, M Labussiere, K Mokhtari, P Zoppoli, ...
Clinical cancer research 21 (14), 3307-3317, 2015
2462015
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20